Abstract #0354

Staging hemodynamic failure: BOLD fMRI cerebrovascular reactivity beats [15O]-H2O-PET.

Marco Piccirelli¹, Christiaan van Niftrik², Geoffrey Warnock³, Susanne Wegener⁴, Athina Pangalu¹, Giuseppe Esposito², Antonios Valavanis¹, Alfred Buck⁵, Andreas Luft⁴, Oliver Bozinov², Luca Regli², and Jorn Fierstra²

¹Neuroradiology, University Hospital Zurich, Zurich, Switzerland, ²Neurosurgery, University Hospital Zurich, Zurich, Switzerland, ³Pharmacology & Toxicology, University Hospital Zurich, Zurich, Switzerland, ⁴Neurology, University Hospital Zurich, Zurich, Switzerland, ⁵Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland

The actual gold standard stroke risk assessment is cerebral blood flow (CBF) measured with [15O]-H2O-PET, which is available only in few specialized centers and requires ~1mSv radioactive dose.

Otherwise, quantitative CVR measurements derived (with our temporal decomposition iterative algorithm) from Blood-Oxygen-Level-Dependent (BOLD) fMRI with CO2 challenge might apply as a surrogate imaging-marker for hemodynamic failure, as the <7 minutes acquisition can easily be clinically implemented, and has – as proved in this study – twice higher specificity*sensitivity for staging hemodynamic failure in chronic cerebrovascular steno-occlusive diseases than PET.

Therefore, BOLD CVR shall be widely implemented for assessing stroke risk.

This abstract and the presentation materials are available to members only; a login is required.

Join Here